🇺🇸 recombinant hemagglutinin influenza vaccine in United States

recombinant hemagglutinin influenza vaccine (recombinant hemagglutinin influenza vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

recombinant hemagglutinin influenza vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is recombinant hemagglutinin influenza vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for recombinant hemagglutinin influenza vaccine in United States?

The University of Hong Kong is the originator. The local marketing authorisation holder may differ — check the official source linked above.